AstraZeneca Says 'No Thanks' to Pfizer - Presented by: The Aol. On Network

AstraZeneca rejected an improved takeover offer from Pfizer worth more than $106 billion, saying the proposal substantially undervalued the company. WSJ's Dana Cimilluca joins MoneyBeat with the details. Photo: Getty.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.931 0.29 ▼ 1.68%
INTC $ 30.64 0.46 ▲ 1.52%
VALE $ 5.80 0.04 ▲ 0.69%
MU $ 19.14 0.36 ▲ 1.92%
PBR $ 8.87 0.22 ▲ 2.54%
XIV $ 40.38 2.92 ▼ 6.74%
AAPL $ 125.9569 0.64 ▼ 0.51%
CMCSA $ 62.35 0.10 ▲ 0.16%

As of 7/2/2015, 12:51 PM